A detailed history of Thornburg Investment Management Inc transactions in Repligen Corp stock. As of the latest transaction made, Thornburg Investment Management Inc holds 35,857 shares of RGEN stock, worth $5.11 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
35,857
Previous 36,605 2.04%
Holding current value
$5.11 Million
Previous $4.61 Million 15.65%
% of portfolio
0.07%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$119.79 - $167.35 $89,602 - $125,177
-748 Reduced 2.04%
35,857 $5.34 Million
Q1 2024

May 13, 2024

SELL
$170.78 - $208.42 $321,066 - $391,829
-1,880 Reduced 4.89%
36,605 $6.73 Million
Q4 2023

Feb 08, 2024

SELL
$114.17 - $185.35 $429,964 - $698,028
-3,766 Reduced 8.91%
38,485 $6.92 Million
Q3 2023

Nov 13, 2023

BUY
$138.78 - $176.51 $208,447 - $265,118
1,502 Added 3.69%
42,251 $6.72 Million
Q2 2023

Aug 08, 2023

BUY
$138.42 - $180.31 $651,681 - $848,899
4,708 Added 13.06%
40,749 $5.76 Million
Q1 2023

May 09, 2023

SELL
$154.26 - $198.1 $232,624 - $298,734
-1,508 Reduced 4.02%
36,041 $6.07 Million
Q4 2022

Feb 07, 2023

SELL
$162.42 - $220.56 $298,203 - $404,948
-1,836 Reduced 4.66%
37,549 $6.36 Million
Q2 2022

Aug 05, 2022

SELL
$140.68 - $188.02 $700,023 - $935,587
-4,976 Reduced 11.22%
39,385 $6.4 Million
Q1 2022

May 12, 2022

SELL
$161.19 - $257.96 $812,075 - $1.3 Million
-5,038 Reduced 10.2%
44,361 $8.34 Million
Q4 2021

Feb 10, 2022

SELL
$247.59 - $304.47 $6.65 Million - $8.18 Million
-26,872 Reduced 35.23%
49,399 $13.1 Million
Q3 2021

Nov 10, 2021

SELL
$194.77 - $324.21 $312,411 - $520,032
-1,604 Reduced 2.06%
76,271 $22 Million
Q2 2021

Aug 11, 2021

BUY
$165.87 - $220.95 $882,594 - $1.18 Million
5,321 Added 7.33%
77,875 $15.5 Million
Q4 2020

Feb 09, 2021

BUY
$148.08 - $206.57 $10.7 Million - $15 Million
72,554 New
72,554 $13.9 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.91B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Thornburg Investment Management Inc Portfolio

Follow Thornburg Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thornburg Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Thornburg Investment Management Inc with notifications on news.